Arrow-right Camera
The Spokesman-Review Newspaper
Spokane, Washington  Est. May 19, 1883

Antipsychotic drug linked to diabetes

Associated Press

WASHINGTON – The Food and Drug Administration and pharmaceutical giant Pfizer Inc. warned doctors that the company’s antipsychotic drug Geodon has been linked to extremely high blood sugar and diabetes.

Pfizer’s warning letter to doctors said “few reports” of hyperglycemia or diabetes were noted in patients prescribed Geodon.

As a whole, so-called atypical antipsychotic drugs were linked to such adverse events as diabetes and high blood sugar.

Geodon, approved to treat schizophrenia, gained FDA approval on Aug. 23 for the treatment of acute bipolar mania.